Top Markets
Coin of the day
Fennec Pharmaceuticals Inc. Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc.

FENC
Rankning i aktier #14216
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical firm. Its leading... Fennec Pharmaceuticals Inc. operates as a biopharmaceutical firm. Its leading investigational drug in clinical development is PEDMARK, a specialized formulation of sodium thiosulfate. This treatment is designed to shield young cancer patients from hearing damage (ototoxicity) that can be induced by platinum-based chemotherapy. The company, which was founded in 1996, previously operated under the name Adherex Technologies Inc. before officially rebranding as Fennec Pharmaceuticals Inc. in September 2014. Its corporate headquarters are situated in Research Triangle Park, North Carolina.
Aktiekurs
$12.33
Senast synkroniserad: 2026-08-31
Marknadsvärde
$428.31M
Förändring (1 dag)
0.49%
Förändring (1 år)
39.01%
Land
US
Handel Fennec Pharmaceuticals Inc. (FENC)

Kategori

Historik för aktiesplit för Fennec Pharmaceuticals Inc. (FENC)
Aktien Fennec Pharmaceuticals Inc. (symbol: FENC) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Sep 01, 2026.
En FENC-aktie köpt före Sep 01, 2026 motsvarar nu 0 FENC-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH